Skip to main content

Cosmos Health Inc.

COSM
Exchange
Nasdaq
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
SEC CIK
0001474167

No open-market purchases or sales by Cosmos Health Inc. insiders were filed in the last 90 days; 30 institutions reported holding it in 13F filings for Q3 2026, worth $3.20M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 19, 2026
$14.4M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +10 vs. previous quarter
30
13F valueReported value at the end of Q3 2026
$3.20M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$65.3M
+19.9% year over year
Net income, FY2025
-$19.1M
No comparable prior period
Free cash flow, FY2025
-$8.50M
No comparable prior period
Revenue, Q2 FY2026
$19.0M
+28.8% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $19.1M (29.3% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
1.77M
Shares sold short
Change
−511.7K
−22.4% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding COSM, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding COSM at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Cosmos Health Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 31, 2026 (view filing)11:52 AM ETJul 301 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+349.8K$0.2001+$70.0K+2.5%14.6M after
Jul 30, 2026 (view filing)11:09 AM ETJul 291 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+766.3K$0.1827+$140.0K+5.7%14.2M after
Jun 17, 2026 (view filing)9:15 AM ETJun 161 dayTerzis GeorgiosChief Financial OfficerPPurchaseCommon Stock, par value $.001+168.1K$0.2498+$42.0K+8.1%2.24M after
Jun 12, 2026 (view filing)1:22 PM ETJun 111 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+218.4K$0.206+$45.0K+1.6%13.5M after
Jun 12, 2026 (view filing)6:20 AM ETJun 102 daysSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+701.4K$0.2281+$160.0K+5.6%13.3M after
Feb 13, 2026 (view filing)10:05 AM ETFeb 121 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+388.5K$0.3732+$145.0K+4.6%8.86M after
Feb 12, 2026 (view filing)2:20 PM ETFeb 111 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+291.3K$0.412+$120.0K+3.6%8.47M after
Jan 26, 2026 (view filing)Jan 233 daysSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+90.3K$0.50+$45.2K+1.1%8.18M after
Jan 21, 2026 (view filing)Jan 201 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+353.3K$0.50+$176.7K+4.6%8.09M after
Jan 15, 2026 (view filing)9:40 AM ETJan 141 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+493.5K$0.4458+$220.0K+6.8%7.74M after

Top 10 13F holders, Q3 2026

See all 30 holders

The largest institutional positions in Cosmos Health Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding COSM in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Wells Fargo & Company5,119,640$2.20M0.00%+5,119,600+12,799,000.0%Added
Geode Capital Management, LLC405,390$174.3K0.00%+123,296+43.7%Added
UBS Group AG352,799$151.7K0.00%−241,663−40.7%Reduced
Vanguard Capital Management LLC304,117$130.8K0.00%+130,151+74.8%Added
BlackRock, Inc.267,797$115.1K0.00%00.0%Unchanged
Vanguard Fiduciary Trust Co148,175$63.7K0.00%−185,667−55.6%Reduced
Susquehanna International Group, LLP138,280$59.4K0.00%+138,280New
Citigroup Inc113,138$48.6K0.00%+113,095+263,011.6%Added
Virtu Financial LLC111,609$48.0K0.00%+111,609New
XTX Topco Ltd80,329$34.5K0.00%+80,329New

Holders of 5% or more of COSM

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cosmos Health Inc..

Largest holders of COSM from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Siokas Grigorios13D/A22.90%6.87M shares+6.30 ppfrom 16.60%Feb 12, 20219 filingsMay 27, 2025SEC
Bovopoulos Andreas13G/A10.00%3.73M shares–Mar 10, 20261 filingMar 10, 2026SEC
Bovopoulos Andreas13G/A8.10%8.12M shares+1.20 ppfrom 6.90%Mar 6, 20257 filingsNov 12, 2026SEC
Wells Fargo & Company13G5.10%5.12M sharesNewOct 29, 20261 filingOct 29, 2026SEC